These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8813436)

  • 21. Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer.
    Wittenberg J; Cook LS; Rossing MA; Weiss NS
    Epidemiology; 1999 Nov; 10(6):761-3. PubMed ID: 10535792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analgesic drug use and risk of epithelial ovarian cancer.
    Hannibal CG; Rossing MA; Wicklund KG; Cushing-Haugen KL
    Am J Epidemiol; 2008 Jun; 167(12):1430-7. PubMed ID: 18390840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study.
    Risch HA; Marrett LD; Jain M; Howe GR
    Am J Epidemiol; 1996 Aug; 144(4):363-72. PubMed ID: 8712193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.
    Poole EM; Merritt MA; Jordan SJ; Yang HP; Hankinson SE; Park Y; Rosner B; Webb PM; Cramer DW; Wentzensen N; Terry KL; Tworoger SS
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):429-37. PubMed ID: 23307531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leisure-time physical activity in relation to breast cancer among young women (Washington, United States).
    Chen CL; White E; Malone KE; Daling JR
    Cancer Causes Control; 1997 Jan; 8(1):77-84. PubMed ID: 9051326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
    Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
    Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group.
    John EM; Whittemore AS; Harris R; Itnyre J
    J Natl Cancer Inst; 1993 Jan; 85(2):142-7. PubMed ID: 8418303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An epidemiologic study of ovarian cancer. Part 11: Oral contraceptive use and menstrual events.
    Badawy YA; Bayoumi DM
    J Egypt Public Health Assoc; 1992; 67(5-6):579-91. PubMed ID: 1294683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women.
    Qin B; Moorman PG; Alberg AJ; Barnholtz-Sloan JS; Bondy M; Cote ML; Funkhouser E; Peters ES; Schwartz AG; Terry P; Schildkraut JM; Bandera EV
    Br J Nutr; 2016 Feb; 115(4):694-702. PubMed ID: 26669283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast-feeding and risk of epithelial ovarian cancer.
    Jordan SJ; Cushing-Haugen KL; Wicklund KG; Doherty JA; Rossing MA
    Cancer Causes Control; 2012 Jun; 23(6):919-27. PubMed ID: 22527170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial ovarian cancer risk among women with polycystic ovary syndrome.
    Schildkraut JM; Schwingl PJ; Bastos E; Evanoff A; Hughes C
    Obstet Gynecol; 1996 Oct; 88(4 Pt 1):554-9. PubMed ID: 8841217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Peeters PH; Lukanova A; Allen N; Berrino F; Key T; Dossus L; Rinaldi S; van Gils CH; Bueno-de-Mesquita HB; Boeing H; Schulz M; Chang-Claude J; Linseisen J; Panico S; Sacerdote C; Palli D; Tumino R; Trichopoulou A; Trichopolos D; Bamia C; Larranaga N; Ardanaz E; Pera G; Quirós JR; Martínez-García C; Navarro C; Bingham SA; Khaw KT; Clavel F; Tjonneland A; Olsen A; Overvad K; Tetsche MS; Lund E; Lundin E; Berglund G; Riboli E; Kaaks R
    Endocr Relat Cancer; 2007 Mar; 14(1):81-90. PubMed ID: 17395977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraceptive and benign ovarian tumors.
    Westhoff C; Britton JA; Gammon MD; Wright T; Kelsey JL
    Am J Epidemiol; 2000 Aug; 152(3):242-6. PubMed ID: 10933271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of breast cancer among young women: relationship to induced abortion.
    Daling JR; Malone KE; Voigt LF; White E; Weiss NS
    J Natl Cancer Inst; 1994 Nov; 86(21):1584-92. PubMed ID: 7932822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.
    Nader S; Riad-Gabriel MG; Saad MF
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3074-7. PubMed ID: 9284746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.
    Whittemore AS; Balise RR; Pharoah PD; Dicioccio RA; Oakley-Girvan I; Ramus SJ; Daly M; Usinowicz MB; Garlinghouse-Jones K; Ponder BA; Buys S; Senie R; Andrulis I; John E; Hopper JL; Piver MS
    Br J Cancer; 2004 Nov; 91(11):1911-5. PubMed ID: 15545966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of comorbidity on mortality in ovarian cancer patients.
    Stålberg K; Svensson T; Lönn S; Kieler H
    Gynecol Oncol; 2014 May; 133(2):298-303. PubMed ID: 24582801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.